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ABSTRACT
Dietary calcium exerts an anti-obesity effect, and dairy exerts about twice the
activity as supplemental calcium. Milk contains angiotensin converting enzyme inhibitors
(ACEi) and a high concentration of branched chain amino acids (BCAA), both of which
may contribute to an anti-obesity effect through effects on lipid metabolism and muscle
protein synthesis, respectively. To test this hypothesis, aP2-agouti transgenic mice were
maintained for 6 weeks on an obesigenic soy based diet and then randomized into an ad
libitum control group and energy restricted (70% of ad lib) diets containing soy protein
(0.4% Ca), non-fat dry milk (NFDM; 1.2% Ca) or Ca-depleted NFDM (0.4% Ca) for an
additional 6 weeks; the soy diet was provided with or without an ACEi and BCAA
supplement and provided at either 0.4 or 1.2% Ca. The NFDM group exhibited ~2-fold
greater reduction in body weight and fat than the energy restricted group (p<0.01), and
the Ca-depleted milk group exerted 60% of the effect of intact milk (p<0.01); this effect
was replicated by the ACEi/BCAA supplemented diet, and addition of calcium to this
diet resulted in further weight and fat loss. Overall, the Ca, ACEi and BCAA content of
milk accounted for ~90% of its anti-obesity activity. Moreover, diets with native or
supplemented BCAA attenuated muscle loss. These data indicate that Ca is responsible
for ~40% of the anti-obesity effect of milk while BCAA and ACEi are responsible for
much of the additional activity. The results of this study have significance for dieters
wishing to achieve optimal body composition. Dairy components are seen here to help
with fat loss and lean maintenance during calorie restriction, which may then further aid
maintenance of weight loss.
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CHAPTER 1. INTRODUCTION
The prevalence of obesity has grown dramatically over the past three decades. In
the early 1960s only 31.5% of the American population was classified as overweight, and
13.3% as obese. Now, less than 50 years later, almost 35% of the population is
overweight, and another 30% are obese1. Overweight and obesity are highly correlated
with other chronic diseases as well. Many people with a body mass index over 25 also
have hypertension, hyperlipidemia, insulin resistance, and hyperglycemia1. People with
any three of these problems are at increased risk of morbidity and mortality2. Many lines
of research have been conducted in recent years to find mechanisms of these disorders,
and therefore possible cures or lifestyle interventions that could be used to stop the
downward spiral of chronic disease in the United States.
One recent line of research in the field of obesity is the role of calcium in
modulating lipid metabolism. Intracellular calcium ([Ca2+]i) stimulates de novo
lipogenesis and inhibits lipolysis in both human adipocytes and obesity-prone transgenic
mice3-5. Similarly, low calcium diets induce fat gain and inhibit fat loss in mice, whereas
high calcium diets impede energy storage6 Several epidemiological studies have shown a
strong negative correlation between calcium intake and body fat and obesity7-13 and milk
products enhance the effect of calcium on fat metabolism14, 15, 16.
The compounds in milk that enhance the anti-obesity effect of calcium are not yet
known. However, there are two classes of bioactive compounds that show promise. The
first of these compounds, angiotensin converting enzyme inhibitors (ACEi) have long
been found in milk17, 18. ACEi stop the formation of angiotensin II which has been shown
to inhibit preadipocyte differentiation19, possibly contributing to insulin resistance, and to
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stimulate hypertrophy in mature human adipocytes20 through stimulation of fatty acid
synthase (FAS) gene expression and activity, leading to increased triglyceride content of
adipocytes. Thus, we have hypothesized that ACEi derived from milk could inhibit the
formation of AII, thereby decreasing the availability of the substrate to increase
triglyceride synthesis and storage. The second of these compounds is leucine, one of the
branched chain amino acids (BCAA). Leucine has been shown to stimulate muscle
protein synthesis via the mTOR and other pathways21, 22 leading to muscle maintenance
during calorie restriction23, 24.
Consequently, the objective of this study was to determine the contributing roles
of calcium, ACEi and BCAA to the anti-obesity effect of milk. Specifically, we
compared differing sources of protein and differing levels of calcium, ACEi and BCAA
in calorie-restricted diets in their effects on weight and fat loss, and regulation of fat
metabolism and gene expression in transgenic mice.
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CHAPTER 2. LITERATURE REVIEW
I. Mechanisms of adipogenesis, fatty acid synthesis and lipolysis
Key to elucidating the cause of obesity is to understand the mechanisms that lead
to fat storage and release. Adipose tissue mass is determined at three levels of regulation:
adipogenesis, fatty acid synthesis and lipolysis. The first phase in this cycle is that of
adipogenesis- the creation and lipid-expansion of new fat cells. Preadipocyte
differentiation has primarily been studied in vitro because the complex nature of adipose
tissue makes in vivo studies difficult. Differentiation is stimulated by insulin and
glucocorticoid25, which is a phosphodiesterase (PDE)- inhibitor, and further stimulated by
growth hormone, CCAAT/enhancer binding protein α (C/EBP-α), and peroxisome
proliferator-activated receptor-γ (PPAR-γ), among other factors, reviewed by Gregoire26.
The second part of adipose metabolism is fatty acid synthesis leading to hypertrophy of
adipocytes. This process is promoted by increased levels of intracellular glucose via the
action of insulin and inhibited by glucagon and a high-fat diet. It is also stimulated by
glucocorticoid, and allosterically by high levels of cytosoilic citrate. Citrate is a precursor
for malonyl-CoA, which when combined with acetyl-CoA begins the fatty acid synthase
(FAS) cycle. The last part of lipid metabolism is lipolysis. This pathway is usually
stimulated by adrenaline or noradrenaline27. Adenylyl cyclase forms cyclic adenosine
monophosphate (AMP), which goes on to stimulate hormone sensitive lipase (HSL).
HSL is the enzyme responsible for breaking a triacylglycerol into a monoacylglycerol.
Cyclic AMP is inactivated by PDE, which changes the messenger into non-cyclic AMP.
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II. Role of calcium in obesity
A. Agouti mice- a model for obesity
In order to study the mechanisms leading to obesity, researchers need an in-vitro
model. One mouse model that displays a similar pattern of obesity as humans is the
agouti yellow-mouse. The agouti gene encodes a 131-amino acid protein28. Normal
expression of agouti protein occurs transiently in the hair follicles of infant mice, acting
as a melanocortin receptor antagonist, resulting in a subapical yellow band of the
otherwise black hair29. Initially it was found that mice over-expressing agouti protein
systemically have yellow fur, become obese, and are insulin resistant29. These metabolic
problems were explained when later it was discovered that the agouti gene product
regulates calcium signaling, and that it inhibits lipolysis by means of a calciumdependent mechanism4, 30.
Humans express a protein that is 80% homologous to mouse agouti protein called
agouti signaling protein or ASIP. This protein is expressed mainly in adipose and
pancreas tissue31, 32. Because mouse agouti protein is known to act chiefly by
antagonizing melanocortin receptors, it has been hypothesized that these proteins are also
the chief effector of ASIP’s actions in human adipose metabolism. Scientists created
mice in the 1990s to over-express agouti specifically in the adipose tissue of yellow mice
under control of the aP2 promotor33, imitating to the normal expression of ASIP in
human adipose tissue to be used as a model to explore obesity.
B. Calcium signaling in lipid metabolism
Using the agouti mouse model as well as cultured adipocytes, the role of calcium
signaling in adipocyte lipid metabolism has been further elucidated. It was found that
4

lipolysis stimulated by either ACTH or forskolin is inhibited in both human and 3T3-L1
adipocytes while intracellular calcium ([Ca2+]i) is elevated4 . Later it was found that this
is effected via activation of phosphodiesterase 3B and resulting reduction of cyclic
AMP5. Correspondingly, it was found that agouti gene product also stimulates
lipogenesis via fatty acid synthase stimulation34 through increased [Ca2+]i35. This led to
a milestone study that combined work in human adipocytes, an in vivo study of weight,
core temperature and lipid metabolism change in obesity-prone mice fed diets with
differing amounts of calcium and dairy, and an epidemiological study of the NHANES III
data set10. In the first part of this study, cultured human adipocytes showed sustained
dose-responsive increases in [Ca2+]i to both 1,25-dihydroxyvitamin-D3 [1,25(OH)2D] and
PTH, and a corresponding decrease in basal and stimulated lipolysis. It was concluded
that the key hormones that regulate serum calcium levels also regulate adipocyte calcium
channels. Both 1,25(OH)2D and PTH are known to become elevated in individuals
consuming low amounts of calcium; therefore, it is possible that low calcium diets
induce calcitrophic hormones which then induce increases in [Ca2+]i, resulting in lipid
accumulation via stimulation of lipogenesis and inhibition of lipolysis. 1,25(OH)2D has
been shown to augment cortisol production via 11-β- hydroxysteroid dehydrogenase-136,
which has in turn been implicated in adipogenesis, particularly in visceral fat depots37.
Although this enzyme appears to be less active in the livers of obese individuals, 11-βHSD-1 has been shown to be more active in the adipose tissue in humans38 and fatty rats,
which only become obese in the presence of glucocorticoid39. It has since been shown
that 1,25 (OH)2D stimulates cellular Ca2+ influx via non-genomic actions40, 41. It is
possible that the actions of 1,25(OH)2D on cortisol production and adipogenesis are
5

accomplished via calcium signaling. It remained to be found how these cellular effects
played out in the body, whether animal or human.
C. Animal experiments linking calcium intake to lower body weight
In multiple experiments using mice, Zemel and associates found that dietary
calcium inhibits de novo lipogenesis, and increases lipolysis, whether the mice were
being fed ad libitum, on calorie restricted diets, or regaining weight lost after calorie
restriction10, 42, 43. It was also found that diets high in dairy had an even more profound
effect on these measures of adipocyte metabolism than did calcium supplementation
alone10, 42, 43. In the first of these experiments, Zemel utilized aP2-agouti transgenic
mice, which exhibit a similar pattern of obesity-related genes as humans10. On a standard
AIN-93G diet these mice are normal weight, but if fed a diet high in sucrose and fat
(obesigenic diet), they rapidly become moderately obese44. These mice were fed ad
libitum for six weeks either a obesigenic diet with low (0.4%) or high (1.2%) levels of
calcium carbonate, or the same diet with 50% or 100% of the protein replaced with nonfat dry milk to provide 1.2% and 2.4% calcium, respectively. The mice with elevated
calcium intake gained significantly less weight than those on the control, low calcium
diet. Of these, the mice consuming the most dairy with the highest calcium intake gained
the least weight. FAS gene expression and activity were significantly lower in the
calcium and dairy mice than the control mice. Likewise, lipolysis was significantly
higher in these mice10. Thus it was concluded that calcium and dairy have a profound
effect on fat metabolism in both limiting de novo lipogenesis and by increasing lipolysis.
The second of these experiments studied of the effect of calcium and dairy on
body composition and fat metabolism during energy restriction42. Animals were fed an
6

obesigenic, low-calcium diet for 6 weeks, then were divided into five diet groups, four of
which were fed the same diets as those in the previous study10, but at 70% of the kcal
consumed by the fifth ad libitum group. Mice maintained on the high-calcium diet lost
more weight and fat than those on the restricted basal diet, and those consuming the
higher dairy diets lost even more weight. Adipocyte [Ca2+]i decreased substantially from
the ad libitum diet with the high-calcium diets, but not at all with simple kcal restriction.
FAS activity and expression decreased significantly with added calcium, dairy and kcal
restriction. Furthermore, lipolysis was significantly increased by the high-calcium diet
over both basal diets, and even further by both dairy diets.
The third experiment studied the effect of calcium and dairy products in weight
regain43. Obesity was induced in transgenic mice, followed then by a calciumsupplemented cereal energy-restricted diet to produce weight loss in all the mice. This
weight loss was followed by a weight-regain phase. Mice were fed ad libitum one of five
diets including the obesigenic ad libitum and calcium carbonate-supplemented cereal
diets of the first two phases, as well as a milk protein supplemented diet, a yogurt-based
diet, and a low calcium cereal diet. The results of this study showed a significantly
smaller weight regain in mice fed the high-calcium and dairy-based diets than those fed
either of the control diets. It also showed that the high-calcium diet group gained
significantly less fat than the ad libitum and cereal control groups, and that both dairy
groups gained even less than the calcium group, echoing the results from the previous
two studies. This study again showed a marked inhibition of FAS and an increase in
lipolysis in the calcium diet and even more profound effects in the dairy-based diet. All
these results occurred despite the fact that the mice were eating the same amount of
7

calories, indicating that calcium and other components of dairy do in fact affect energy
partitioning.
Although the effects of high calcium diets on obesity prevention were firmly
established in mice, it remained to be studied how calcium and dairy intake affects
humans’ weight and body fat distribution.
D. Clinical trials of the role of calcium in weight loss
The findings from animal studies prompted researchers to begin to study the
effect of a high calcium diet in humans. In one study, 32 obese but otherwise healthy
adults were randomized to one of three weight loss diets for 24 weeks45. The control diet
provided a 500 kcal/day deficit, low calcium and dairy intake plus a placebo supplement,
providing 400-500 mg/day calcium. A calcium-supplemented diet was identical to the
control diet, except that the placebo was replaced with an 800 mg/day calcium
supplement, providing a total of 1200-1300 mg/day calcium. The last diet group was
assigned a 500 kcal/day deficit, high-dairy diet plus a placebo supplement, providing
1200-1300 mg/day calcium from a dietary rather than supplemental source. At the end of
the trial all subjects lost weight, however, the weight loss in the higher calcium groups
was markedly greater than that of the low calcium group. The low calcium group lost an
average of 6.4% of their body weight and 8.1% of their body fat, whereas the calciumsupplemented group lost 8.6% and 11.6% and the high-dairy lost 10.9% and 14.1% of
their body weight and body fat, respectively. The higher calcium groups also lost much
more trunk fat as a percentage of their total fat loss. Of these two diets, however, the
dairy group again showed a significantly greater fat loss than the calcium group, with

8

66.2% of their total fat loss coming from the trunk region as opposed to 50.1% total fat
being lost from the trunk in the calcium-supplemented group.
In another study16, 38 healthy overweight subjects were placed on one of two 500calorie deficit diets: the first low in calcium (400-500 mg/day) and dairy and the second
providing three six-ounce servings of yogurt a day (1100 mg calcium/day). After 12
weeks, all subject lost weight, however, those subjects consuming the yogurt diet lost
22% more weight, 61% more fat and 31% less lean mass than the low calcium group.
The yogurt group also had a profound decrease in trunk fat (81% more than the control
group), waist circumference and blood pressure, and a significant increase in lipolysis of
22.3%. A trial of dairy products on body composition and weight loss in AfricanAmericans showed similar results15. On a eucaloric diet, the group consuming the low
calcium (500 mg/d) low-dairy diet had no changes in body composition, but those who
ate three servings of dairy each day (1200 mg Ca/d) had decreased body fat by about 2
kg, trunk fat by about 1 kg, as well as lowered insulin and blood pressure. Similarly,
when these diets were modified to be calorie restricted in a second part of the clinical
study, the high-dairy group lost about twice as much weight and fat as the low-dairy diet.
Lean weight was maintained much better in the high-dairy group in that they lost only
13% as much as the low-dairy group. A significant drop in fasting insulin was observed
with the high-dairy diet, and this group also lost over 4 kg of trunk fat compared to less
than 1 kg lost by the low-dairy group.
Not all clinical trials conclude that calcium has an effect on weight loss, however.
In a study by Bowen, et al.46, 50 overweight people placed on either a diet high in dairy
protein and calcium (2400mg/d), or a diet high in mixed protein / low calcium (500mg/d).
9

This study found that there was no difference between weight, fat, trunk fat or lean loss
between the groups after 16 weeks of energy restriction. It is difficult to compare this
study to the others discussed, however, because both of the experimental diets were high
in protein (34%), which has been shown to enhance weight loss, and all groups lost about
9 kg during the 12 weeks of energy restriction, maximizing the amount of weight loss
possible, leaving little room for calcium to have any apparent effect. Furthermore, the
baseline calcium intake of all of these groups was over 700 mg per day, about 200mg
higher than other trials15, 16, 45 studying calcium’s role in weight loss. Another study47
compared diets with differing levels of calcium and fiber in 90 obese subjects for 48
weeks. This study also found no difference in weight and fat loss between the diet
groups; however, the authors speculated that the lack of significant difference was due to
the “threshold effect” which could not be observed in this trial due to lack of a lowcalcium diet group. The idea that a minimum amount, or threshold, of calcium intake is
required to maintain sufficiently low calcitrophic hormones and [Ca2+]i to keep lipid
accumulation low was first suggested by Thompson et al. and has been supported by
several studies16, 45, 47-49. Based on these studies, it has been hypothesized that this
threshold is about 600mg of calcium per day.
E. Retrospective studies linking calcium to weight loss
Longitudinal, reanalysis of bone-density and other studies conclude that calcium
and dairy have an effect on body composition. A longitudinal study of pre-school
children12 showed that those with the highest dairy, calcium, and monounsaturated fat
consumption tended to have the lowest body fat as measured by dual-energy x-ray
absorptiometry (DEXA). In a later study of 8 year olds, it was found that calcium intake
10

was again negatively associated with percentage of body fat13. A second study completed
soon after Zemel’s NHANES III analysis also found that calcium is related to body
composition in young women 8. The study was originally designed to assess the
relationship between exercise and body composition, but the study design was easily
adapted to assess the relationship between dietary factors and body composition.
Subjects in this study were sedentary white females who were partitioned either to a
control group or an exercise group for two years. Fifty-four of these women had enough
dietary records for the researchers to reanalyze results to determine if a relationship
existed between calcium intake and body composition as determined by DEXA.
Statistical regression calculations showed that the ratio dietary calcium to energy
(mg/kcal) showed significant negative correlation to body weight and fat; in other words,
the more calcium a person consumes relative to calories, the less that person is likely to
weigh. The investigators noted that the effect of calcium in this case was specific to
dairy calcium, but it is possible that there are other components in dairy that affect body
composition, or that there is a threshold level of calcium needed to have any effect, and
that dietary sources of the nutrient are essential to achieving this level. Along the same
lines, in 2000 the Osteoporosis Research Center reanalyzed their studies from the past 12
years and found that among 780 women of differing ages, there were significant negative
correlations between body weight and calcium intake, and that for young women,
calcium intake below the median equated to an odds ratio of 2.25 for being overweight9.
The exercise intervention study 8 also found that total calcium but not energy
intake predicts changes in fat mass in those women with intakes lower than the median
amount of calories, but that energy and not total calcium predicts changes in fat mass in
11

women with higher caloric intake. In assessing the difference between the effect of
calcium on body composition between the higher and lower calorie intake groups, Lin et
al. hypothesize that higher energy intakes could overwhelm the effect of calcium. This is
significant when considering the role of calcium in weight loss diets.
A recent study on calcium supplementation and weight change after 10 years50
found that in men, calcium from the diet, supplements or both sources has little effect on
weight change between the ages of 45 and 57 years, but that in women of the same age
current and past supplement use are predictors for weight change. Women who took the
most calcium gained the lease amount of weight. Interestingly, dietary calcium did not
have a significant effect on weight gain, but dietary plus supplementary calcium did show
a significant trend of weight maintenance in the higher quartiles of intake.
Despite these findings, some researchers have found that calcium has no effect on
weight loss. A study on the effect of supplemented calcium on weight and fat loss in preand post-menopausal women found little correlation between the mineral and change in
body composition51. This study may differ from many of the others because the mean
baseline calcium intake of the groups was higher than 600 mg/day, the suggested
“threshold.” Also, all the calcium was supplemented via pill form, rather than through
adding dairy products to the diet. Nonetheless, it raises the question of what levels of
intake and in what form calcium becomes effective in promoting healthy body
composition, and in what populations calcium supplementation is most beneficial.
F. Epidemiological support for the anti-obesity effect of calcium
The findings from the first published animal study using the conceptual
framework of intracellular calcium as a modulator of adipocyte lipid metabolism
12

prompted Zemel et al. to investigate epidemiological evidence for a relationship between
calcium or dairy and weight. In the first of these studies, the NHANES III data set was
analyzed by dividing the sample (380 women and 7114 men) into quartiles of dairy
consumption10. Compared to the lowest quartile of dairy consumption with an odds ratio
(OR) of being in the highest quartile of body fat set at 1.00, the highest quartile for dairy
consumption had an OR of 0.16 for being in the highest body fat quartile. This took into
account both energy intake and physical activity, indicating that for any level of either of
these parameters, those people who consumed the most dairy were at a much lower risk
of being in the highest body fat quartile.
As increasing numbers of studies on calcium’s inverse relationship with
overweight were published, the researchers conducting the CARDIA prospective study
reevaluated the results from the first ten years of their study (1985-1995) for any
relationship between calcium and the indicators of metabolic syndrome 7. Of all of the
foods and nutrients assessed, only dairy, fiber and protein showed any association with
metabolic syndrome. Researchers found that for overweight individuals, “there was a
consistent reduction in incidence for each of the four components with increasing
categories of dairy intake” but that the relationship was weaker in normal-weight
individuals. They also found that incidence of metabolic syndrome decreased by more
than 50% in overweight individuals with the highest dairy intakes from those with the
lowest dairy intakes. Little evidence for confounding by other dietary and lifestyle
factors were found when they were factored into odds ratios models. When the odds ratio
for having metabolic syndrome was set at 1 for overweight individuals with the lowest
dairy intake, researchers found highly significant odds ratio of 0.28 for people with the
13

highest dairy intake in a model including demographics, lifestyle factors as well as
dietary fiber and protein. Similar results were found regardless of whether other dietary
factors were included in models.
Mirmiran et al. found that subjects in the Tehran Lipid and Glucose Study who
had the 462 subjects studied, those who had the highest BMIs had the lowest
consumption of dairy products, and the group with the highest dairy consumption had the
highest proportion of normal weight people52. The HERITAGE study of the interaction
between calcium intake and BMI separated sex and race for statistical analysis53. It
found that black and white men and white women tended to have decreasing incidences
of overweight and obesity as calcium consumption went up, but that black women had
increasing incidence of overweight and obesity as calcium intake increased. Not only
was increased calcium consumption correlated with lower body weight in three of four
groups, but it also showed an inverse relationship with abdominal adiposity in black men
and white women.
Another prospective study, the Quebec Family Study, followed changes in selfreported eating patterns and change in weight, body fat, skinfold thickness and waist
circumference over a six year follow-up period 54. People who ate less fat and more fruit
and milk between the first and second data collection times tended to have a decrease in
weight and other body fat indicators over the interim. When change in physical activity
was accounted for in the researchers’ statistical model, the effect of milk was no longer
apparent, indicating that increased energy expenditure can overwhelm the effect of
increased milk consumption, much like the findings of Lin et al8.
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III. Role of the renin-angiotensin system in obesity
Although the preponderance of the data indicates that dairy exerts a greater effect
on body weight and body composition than can be explained by its calcium content, the
dairy components responsible for this additional activity have not yet been identified.
However, two components of dairy seem the most likely to account for this difference.
Dairy has long been recognized to contain both angiotensin converting enzyme inhibitors
(ACEi)55 and a high concentration of the branched chain amino acids (BCAA). ACEi are
primarily associated with antihypertensive action by inhibiting the major step in the
renin-angiotensin system17, 18. It has been shown that at least two of the antihypertensive
proteins found in milk are absorbed intact in adults56, and that regular ingestion of sour
milk containing these peptides results in significantly lower blood pressure57, 58. Studies
of the DASH diet, a diet high in fruit, vegetables, and milk, have commonly attributed the
hypotensive effect to increased calcium intake59, 60; however, it is likely that more than
that one nutrient in milk is the cause of this effect. Indeed, it was found in one metaanalysis that dietary sources of calcium had a two-fold greater effect versus supplemented
calcium on blood pressure reduction61, 62.
Over the past twenty years, it has been shown that adipose tissue contains all of
the components of the renin-angiotensin system63, 64, and is therefore capable of
contributing significantly to the body’s pool of AII thereby increasing blood pressure.
Animal models confirm the link between adiposity and hypertension. Mice lacking
adipose-produced angiotensinogen (AGT) have significantly lower blood pressure than
wild type mice, and are markedly smaller and less fat than wild-type mice65, 66.
Angiotensin type 2 (AT2) receptor null mice are also significantly less fat with smaller
15

adipocytes than wild type mice, and have lower blood pressure even while maintained on
a high-fat diet67. Likewise, Zucker fatty rats display increased levels of adipocyteproduced AGT after weaning compared to lean rats, which show no change in production
of AGT after weaning68 concurrent with the largest growth in adipose tissue, indicating
that the hormone is linked to adipose tissue hypertrophy.
It has also been shown that preadipocytes respond to angiotensin II (AII) by
differentiating into mature fat cells69, 70, creating a feedback loop resulting in adipocyte
differentiation, AGT/AII production, preadipocyte stimulation, adipocyte differentiation.
Likewise, AII has been shown to increase lipogenesis in human adipocytes and 3T3-L1
adipocytes20. Some researchers71 have attributed the link between AGT and adiposity to
AGT’s final product, AII, based on in vitro studies linking AII to preadipocyte
differentiation. However, Janke et al. found that locally produced AII has an antidifferentiation effect19. One study using human adipocytes found no correlation between
production of AGT and cell size, obesity phenotype or blood pressure; however, people
with a specific single nucleotide polymorphism tended to have higher blood pressure, and
exhibited significantly smaller adipocytes, which tended to produce more AGT72. It is
difficult to draw the line between species differences, and differences in AII receptors
when describing the role of the RAS in adipose tissue enlargement as mice, rats and
human adipocytes have all shown different responses via different receptors to the
hormone.
AII has also been shown to increase FAS gene transcription20 and activity73 in
adipose cell lines, but to have no effect on lipolysis in human subjects74. ANG is
converted into AII via angiotensin converting enzyme. If the effect of ANG on adipose
16

hypertrophy is indeed brought about by its conversion to AII, and this hormone’s
subsequent effects on adipocyte growth, differentiation and metabolism, then the
inhibition of this enzyme would be beneficial in controlling adiposity as well as blood
pressure.
IV. Branced-chain amino acids in protein synthesis and weight loss
A. Branced-chain amino acids in protein synthesis
Not only does milk contain bioavailable ACEi, it also contains a large amount of
the branched-chain amino acids, valine, leucine and isoleucine. These amino acids are
found in high proportion in the whey component of milk75. Whey comprises 20% of cow
milk and 80% of human milk. The most noteworthy BCAA is leucine. Leucine
stimulates protein synthesis via the mammalian target of rapamycin (mTOR) pathway by
various initiation factors including eukaryotic initiation factor (eIF) 4F, a translation
initiator, and via unknown mechanisms through eIF4G via its association to eIF4E
(reviewed by Kimball and Jefferson22). Leucine also inhibits the action of eIF4E binding
protein 1, which is a main inhibitor of translation initiation (reviewed in 76). Insulin,
which is released in response to elevated plasma glucose, is another major player in
protein synthesis, also through the mTOR pathway 77. The combined effect of insulin
and leucine on the mTOR and other pathways makes dairy, which contains leucine and
sugars, a likely player in muscle protein synthesis.
B. Leucine in energy restriction
Diets high in protein and the BCAA leucine have been shown to aid in building
and repairing muscle, and to favor fat loss concurrent with muscle sparing during energy
restriction. Rats maintained on a food restricted diet supplemented with leucine lost the
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same amount of weight as their control group on a calorie restricted AIN-93M diet, but
lost significantly more fat mass while maintaining lean mass78. A study of wrestlers on
hypocaloric diets found that those subjects consuming a BCAA diet lost significantly
more weight and fat than those consuming a control, high protein, low protein, and high
carbohydrate diets, and they lost significantly more visceral fat tissue than the other diet
groups24. Similarly, a study of high-altitude trekkers found that those consuming a high
BCAA diet lost weight as the placebo group did, but they tended to gain muscle mass,
whereas the placebo group lost lean mass23. The effects of leucine on protein synthesis
could also account for greater fat and/or weight loss and greater maintenance of lean
mass seen in multiple studies of high-protein vs. high-carbohydrate weight loss diets21, 79,
80

. Diets with a lower carbohydrate to protein ratio also result in lowered serum lipids

and insulin80-83, indicating a role for BCAAs, in contributing to gluconeogenesis,
stabilizing insulin, and protein synthesis, thereby increasing energy demands from lipids.
These muscle-sparing effects are only seen when protein, especially leucine, is supplied
in excess of what is needed for protein turnover, and can be used in stimulating protein
synthesis, and gluconeogenesis.
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CHAPTER 3. CALCIUM, ANGIOTENSIN CONVERTING ENZYME
INHIBITORS AND BRANCHED CHAIN AMINO ACIDS CONTRIBUTE TO
THE ANTI-OBESITY EFFECTS OF MILK
I. Abstract
Recent prospective and epidemiological studies as well as reports from our
laboratory have shown that dietary calcium inhibits weight and fat gain, and promotes
weight loss in mice and humans. Furthermore, dairy sources have been shown to exhibit
a nearly two-fold greater anti-obesity effect than calcium supplementation alone. Dairy
is known to contain other bioactive components including angiotensin converting enzyme
inhibitors (ACEi) and branched chain amino acids (BCAA). Adipose tissue has been
shown to contain all the elements of the renin-angiotensin system, and to respond to
angiotensin II by promoting adipocyte differentiation. One of the BCAA, leucine, has
been shown repeatedly to promote muscle protein synthesis in individuals fed eucaloric
or hypocaloric diets. Methods: To test the hypothesis that ACEi and BCAA contribute to
milk’s anti-obesity effects, we used aP2-agouti transgenic mice, which simulate human
obesity. All mice were maintained for six weeks on an obesigenic soy based diet, then
divided into seven groups including one ad libitum control group and the remaining six
groups on 70% calorie restriction. The restricted diets were as follows: basal diet, non-fat
dried milk (NFDM)-based, depleted calcium NFDM-based, calcium replete NFDMbased, low-calcium soy-based with ACEi and BCAA added, and high-calcium soy-based
with ACEi and BCAA added. At the end of the experiment body weight, fat and muscle
weight, adipocyte intracellular calcium, lipolysis, as well as fatty acid synthase (FAS)
and 11-β- hydroxysteroid dehydrogenase-1 (11-β-HSD) expression were measured.
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Results: All mice on calorie restriction lost weight and fat, with the greatest change noted
in the NFDM and calcium-replete milk-based groups. Soy-based diets with ACEi and
BCAA supplemented lost more weight and fat than the basal soy diet. Mice eating milk
basal diets either gained or maintained muscle mass, while those eating soy based diets
with added ACEi and BCAA gained gastrocnemius mass, and lost less soleus mass than
the restricted basal group. Intracellular calcium was elevated in all the low calcium diet
groups while lipolysis was increased in all of the milk-based groups, with the greatest
increase in the high-calcium milk groups. FAS expression was decreased significantly in
all groups with ACEi and BCAA, particularly in the high-calcium groups. 11-β-HSD
expression was also decreased in the milk groups and high-calcium groups. Conclusion:
Milk, with and without calcium causes a marked anti-obesity effect when consumed by
aP2-agouti transgenic mice. Furthermore, ACEi and BCAA contribute to the alterations
in lipid metabolism in this mouse model.
II. Introduction
Previous research has shown the importance of calcium signaling in modulating
cellular lipid metabolism. Intracellular calcium ([Ca2+]i) stimulates de novo lipogenesis
and inhibits lipolysis in both human adipocytes and obesity prone transgenic mice3-5.
Similarly, low calcium diets induce fat gain and inhibit fat loss in mice, whereas high
calcium diets impede energy storage6. Acute calcium intake by normal weight adults has
been associated with increased fat oxidation84. Several epidemiological studies have
shown a strong negative correlation between calcium intake and body fat and obesity7-13.
It has also been suggested that calcium forms soaps with fat in the gut, thereby decreasing
fat absorption and storage85. Furthermore, it has been shown by our laboratory that a
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high calcium diet fed to transgenic mice suppresses Ca2+ signaling thereby affecting lipid
storage via increased lipolysis and decreased lipogenesis and stimulation of adipocyte
apoptosis86.
Milk products enhance the effect of calcium on fat metabolism. Ad libitum
feeding of aP2-agouti transgenic mice with a high calcium soy-based diet was associated
with lesser weight gain than a low calcium diet, but mice fed a milk based diet gained
even less weight than was explained by the calcium content alone. Similarly, clinical
trials have shown consistent evidence that hypocaloric diets providing 1000 mg or more
of calcium from milk have a greater anti-obesity effect than either supplementing a the
diet with calcium carbonate14, or providing less than 500 mg of calcium 15, 16.
The compounds in milk that enhance the anti-obesity effect of calcium are not yet
known. However, there are two classes of bioactive compounds that show promise.
Milk has long been known to contain angiotensin converting enzyme inhibitors (ACEi)17,
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. These proline-rich proteins are best known for their ability to lower blood pressure by

inhibiting the conversion of angiotensin I into the potent vasoconstrictor angiotensin II
(AII), and by inhibiting the breakdown of the vasodilator bradykinin. A study from our
laboratory testing the anti-hypertensive effect of milk found weight-loss to be an
unexplained side effect of the high dairy diet10. Since the publication of that study, it has
been shown that adipocytes and preadipocytes contain all the elements of the reninangiotensin system, and thus have the ability to contribute to the body’s pool of AII63.
Massiera et al. showed that mice producing no angiotensinogen in their adipose tissue
had significantly lower blood pressure and fat weight than wild type mice, and mice
overproducing angiotensinogen had significantly higher blood pressure and fat weight
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than wild type mice66. It has also been shown that AII stimulates adipocytes to produce
prostacyclin which then induces preadipocyte differentiation69. It is possible that ACEi
found in milk could impede adipose tissue enlargement by interfering with adipose tissue
hyperplasia. It has been shown that low doses of AII stimulate fatty acid synthase (FAS)
gene expression and activity leading to increased triglyceride content of adipocytes20.
Thus, we hypothesized that ACEi derived from milk could stop the formation of AII,
thereby decreasing the availability of the substrate to increase triglyceride synthesis and
storage.
The whey fraction of milk is also known to contain a high proportion of branched
chain amino acids. Of these, leucine stimulates protein synthesis through the insulindependent mammalian target of rapamycin (mTOR) pathway, and through yet unknown
insulin-independent pathways, most likely mediated by the phosphorylation of eukaryotic
initiation factor 4G22. Leucine also acts as the primary nitrogen donor in the conversion
of pyruvate to alanine, the key process in glucose recycling87. Glucose recycling is
essential in gluconeogenesis used in glycemic control. When weight loss occurs, it is
usually a loss of both fat and lean body mass. As lean mass is lost, resting metabolic rate
decreases. Stimulation of protein synthesis through the mTOR pathway by
leucine/BCAA administration is posited to attenuate lean body loss, and therefore help
maintain metabolism and enhance fat loss. A further benefit of a leucine rich diet is
better glycemic control contributing to satiety.
Consequently, the objective of this study was to determine the contributing roles
of calcium, ACEi and BCAA to the anti-obesity effect of milk. Specifically, we
compared differing sources of protein and differing levels of calcium, ACEi and BCAA
22

in calorie-restricted diets in their effects on weight and fat loss, and regulation of fat
metabolism and gene expression in aP2-agouti transgenic mice.
III. Materials and methods
A. Mice and diets
This experiment utilized aP2-agouti transgenic mice, as used in previous
experiments in our laboratory6, 88. These mice exhibit a pattern of agouti and leptin
expression similar to that of humans33. They also are similar to humans in that they are
of normal weight when fed an optimal diet, but gain weight and fat on an obesigenic diet.
These characteristics make aP2- agouti transgenic mice an excellent model for studying
diet-induced obesity.
1. Phase I
Seventy-eight male mice between the ages of 5 and 9 weeks were used for this
experiment. In the first phase, mice were maintained on a modified AIN93G low calcium
(0.4%) soy-protein diet with sucrose as the sole carbohydrate and lard supplementing the
diet to provide 25% kcal from fat, for six weeks (Table 1).
2. Phase II
At the end of this period the mice were randomized to seven diet groups, such
that the mean age and mean weight of each group were not statistically different. One
group of mice (n=9) was maintained on the basal diet fed ad libitum. The remaining
groups of mice were fed energy-restricted (70% kcal ad lib) diets as follows: 1) basal diet
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Table 1: Basal Diet Composition

Protein
(Soy)
Grams % 14.4
Kcal % 14

Carbohydrate Fat
64.8
11
62
24

Fiber
5

Calcium Leucine Isoleucine Valine
0.4
1.14
0.69
0.71

(n=9); 2) basal diet modified by replacing all soy protein with non-fat dry milk (NFDM)
and native calcium level maintained at 1.2% (n=10); 3) a Ca-depleted NFDM protein
diet, with calcium reduced to a level of 0.4% (n=10); 4) milk-protein diet as above, with
calcium (CaCO3) added back to the Ca-depleted NFDM to bring Ca to 1.2% (n=10); 5)
low calcium basal diet supplemented with branched chain amino-acids (BCAA) and ACE
inhibitors from whey (TruCal, Glambia, Wisconsin) equivalent to that in the NFDM
diets (n=10); 6) high calcium basal diet with BCAA and ACE inhibitors added as above,
and calcium supplemented to 1.2% using CaCO3 (n=10) (Table 2). Food intake and
spillage were measured daily for the second six-week phase of this experiment; body
weight was measured weekly.
At the end of the second six-week phase, all the mice were sacrificed by
exsanguination via cardiac puncture while under pentobarbital/phenytoin anesthesia.
Epididymal, retroperitoneal, perirenal and subscapular fat depots were collected,
immediately weighed, and frozen or used in immediate analysis as described below. Real
time RT-PCR was used to analyze FAS and 11β- hydroxysteroid dehydrogenase (11-βHSD) expression in adipose tissues. All animal care and sacrifices were carried out in
accordance with the University of Tennessee Institutional Animal Care and Use
Committee.
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Table 2: Phase II Mouse Diets
Ad Libitum Restricted Diets
Ca
Basal
Basal NFDM Depleted
Protein Source Soy
Soy Milk Milk
Calcium (%) 0.4
0.4 1.2
0.4
Leucine (%) 1.14
1.14 1.33 1.33
Isoleucine (%) 0.69
0.69 0.82 0.82
Valine (%)
0.71
0.71 0.91 0.91

Ca
Replete
Milk
1.2
1.33
0.82
0.91

Low Ca,
ACEi/BCAA
Soy
0.4
1.33
0.84
0.92

High Ca,
ACEi/BCAA
Soy
1.2
1.33
0.84
0.92

B. Lipolysis
Immediately after being excised, perirenal fat was incubated for two hours at 37º
C. Both basal and stimulated glycerol release was measured using a one-step
fluorometric method, as previously described89. The final data were normalized to DNA,
as above.
C. Calcium imaging
Adipocyte intracellular calcium ([Ca+²]i) measurement was performed as
previously described6, 90. Briefly, retroperitoneal adipose tissue was first washed several
times with Hank’s Balanced Salt Solution (HBSS), minced into small pieces, and
digested with 0.8 mg/ml type I collagenase in a shaking water bath at 37 oC for 30 min.
Adipocytes were then filtered through sterile 500-µm nylon mesh and cultured in
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 1% fetal bovine
serum (FBS). Cells were cultured in suspension and maintained in a thin layer at the top
of culture media for 2 h for cell recovery. [Ca 2+]i in isolated mouse adipocytes was
measured by using a fura-2 dual wavelength fluorescence imaging system. Prior to
[Ca2+]i measurement, adipocytes were pre-incubated in serum-free medium for 2 h and
rinsed with HBSS containing the following components (in mmol/L): NaCl 138, CaCl2
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1.8, MgSO4 0.8, NaH2PO4 0.9, NaHCO3 4, glucose 5, glutamine 6,Hepes 20, and bovine
serum albumin 1%. Adipocytes were loaded with fura-2 acetoxymethyl ester (AM) (10
µmol/L) in the same buffer in the dark for 1 h at 37 o C. Adipocytes were rinsed with
HBSS three times to remove extracellular dye and then post-incubated at room
temperature for an additional 30 min to permit complete hydrolysis of cytoplasmic fura-2
AM. A thin layer of adipocytes was plated in 35 mm dishes with glass coverslips (P35G0-14-C, MatTek Corporation, Ashland, MA). The dishes with dye-loaded cells were
mounted on the stage of Nikon TMS-F fluorescence inverted microscope with a Cohu
4915 CCD camera (300w Xenon, Intracellular Imaging Inc, Cincinnati, OH). Fluorescent
images were captured alternatively at excitation wavelength of 340 nm and 380 nm with
an emission wavelength of 520 nm. [Ca2+]i was calculated by using a ratio equation as
described previously6, 90.
D. Total RNA extraction
RNA was extracted from retroperitoneal fat using the Ambion ToTALLY RNA
kit (Ambion, Inc., Austin TX) according to the manufacturer’s instructions. RNA was
resuspended in nuclease free water before quantification using the ND-1000
Spectrophotometer (NanoDrop Technologies Inc., DE), and frozen at –80ºC in aliquots of
10 ng/µl for use in real time RT-PCR.
E. Polymerase chain reaction
Gene expression for FAS and 11-β-HSD, normalized to their corresponding 18S
expression was measured by real time reverse transcriptase- polymerase chain reaction
(RT-PCR) using the 7300 Real Time PCR system with TaqMan universal PCR Master
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Mix, no AmpErase UNG (2X), and reverse transcriptase and RNAse inhibitor from the
TaqMan 1000 Reaction Core Reagent Kit (all from Applied Biosystems, Foster City,
CA), according to manufacturers instructions.
Standard curves were made for each gene of interest by pooling 1µl of each
sample (concentration 10 ng/µl), then using ten-fold dilutions for each progressive
standard point ranging from 100 ng to 0.5 pg total RNA. RT-PCR reaction mixture
contained TaqMan universal PCR Master Mix, no AmpErase UNG (2X), murine
leukemia virus reverse transcriptase (50 U/µl), RNAse inhibitor, and 20X Assays-onDemand Gene Expression Assay Mix for FAS, 11-β-HSD and 18S (all from Applied
Biosystems, Foster City, CA). Polymerase chain reaction was performed according to
instructions of the 7300 Real Time PCR system (Applied Biosystems) using 50 to 100ng
total RNA per sample plated in Thermo-Fast 96Detection plates (ABgene, Epsom,
Surrey, UK). Samples and standards were run in triplicate for best replication and
standard error.
F. Statistical analysis
Data were evaluated for statistical significance using ANOVA, and significantly
different group means were then further analyzed using the least significant difference
(LSD) test. Variables that did not follow the normal distribution were transformed
according to accepted statistical practices before ANOVA. Analyses were performed
with SPSS (SPSS Inc, Chicago, Ill).
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IV. Results
A. Weight Change
All the mice on restricted diets lost weight. The groups fed high calcium milk
based diets lost the most weight (~14 g, p<0.01) with no significant difference between
them (Fig. 1). The mice eating low calcium diets containing either native or
supplemented ACEi and BCAA lost 1.66 to 3.03 g less weight than their respective high
calcium counterparts. Mice eating the high calcium soy-based diet supplemented with
ACEi and BCAA lost significantly less weight than mice on either the regular or the
calcium replete milk diets, but more than those fed the restricted basal diet.
B. Fat Pad Mass
All of the milk fed groups lost significantly more fat than the restricted basal
group (Fig. 2). Of note, the calcium depleted milk diet group lost ~34% (p<0.001) more
fat than the restricted basal group. Addition of ACEi/BCAA to soy diets also resulted in
significant weight loss compared to the restricted basal group; this effect was further
enhanced by calcium.
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Figure 1: Effects of Calcium, ACEi and BCAA on weight change.
Non-matching superscripts denote significant different, p<0.01.
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Figure 2: Effects of Calcium, ACEi and BCAA on fat pad mass.
Non-matching letters denote signifant difference, p<0.001.

C. Gastrocnemius Mass
Mice fed ad libitum had an average gastrocnemius weight of 0.08 g (Fig. 3).
Mice fed the basal restricted diet had significantly lower gastrocnemius weight of 0.072 g
(p<0.01). Mice consuming diets high in either native or supplemented BCAA had
significantly higher muscle weights than those eating food low in BCAA.
D. Soleus Mass
Mice fed a restricted basal diet lost a significant amount of soleus mass compared
to ad lib fed mice (p<0.05) (Fig. 4). Groups that were fed soy diets supplemented with
ACEi/BCAA also lost muscle mass, but to a lesser extent than the low BCAA diet. Mice
fed milk-based diets maintained or gained soleus muscle mass during energy restriction.
E. Adipocyte intracellular calcium
All mice fed low calcium diets had significantly higher [Ca2+]i than mice fed high
calcium diets (p<0.01) (Fig. 5). Mice on all restricted diets had significantly lower
[Ca2+]i than mice fed ad libitum (p<0.01).
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Figure 3: Effects of Calcium, ACEi and BCAA on gastrocnemius
mass. Non-matching superscripts denote significant different,
p<0.01.

Soleus Mass (g)

0.03
0.025
0.02
0.015
0.01

a

b

c

a

a

d

d

Low Ca
+BCAA/ACEi

High Ca
+BCAA/ACEi

0.005
0

Ad Lib

Restricted
Basal

Milk

Ca Depleted
Milk

Ca Replete
Milk

Figure 4: Effects of Calcium, ACEi and BCAA on soleus mass.
Non-matching superscripts denote significant different, p<0.05.
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Figure 5: Effects of calcium, ACEi and BCAA on intracellular calcium.
Non-matching superscripts denote significant difference p<0.01.

F. Lipolysis
Glycerol release increased with all of the restricted diets (Fig. 6). Milk-based diets
caused the greatest increase in lipolysis over the restricted basal diet, with higher calcium
content augmenting this increase (p<0.05). Addition of ACEi/BCAA did not increase
lipolysis in soy fed groups.
G. FAS gene expression
FAS expression of the restricted basal group was not significantly different from
that of the ad libitum group (p<0.05) (Fig. 7). The groups with low calcium showed
about a 25% decrease in FAS expression from the restricted basal group, with no
significant difference between these two groups. FAS expression in the high calcium
milk groups dropped a further 60% compared to the depleted milk group, totaling a drop
in expression of ~75% compared to the restricted basal group. There was no significant
difference in FAS expression between the low and high calcium +BCAA/ACEi groups,
although there was a trend (p<0.10).
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Figure 6: Effects of Calcium, ACEi and BCAA on lipolysis. Nonmatching superscripts denote significant different, p<0.05.
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H. 11-β-HSD gene expression
All energy restricted groups experienced a drop in 11-β-HSD expression
compared to the ad lib fed group (p<0.02) (Fig. 8). The calcium depleted diet group
showed a significant decrease in 11-β-HSD expression compared to the restricted basal
group; this effect was enhanced by 60-80% in high calcium dairy groups. These animals
had about a 90% decrease in 11-β-HSD expression compared to the restricted basal
group. Addition of ACEi/BCAA to soy diets did not change 11-β-HSD expression;
however, addition of calcium to this diet did have a significant effect (p<0.02).
V. Discussion
This study was designed to assess the roles of calcium, ACEi and BCAA in body
composition and adipose tissue metabolism. The results demonstrate that milk’s antiobesity effect is largely due to calcium, ACE inhibitors and branched chain amino acids.
Milk, both intact and calcium replete, caused the largest weight loss in mice, and this
effect was replicated to a lesser extent by the soy diet with added calcium and
ACEi/BCAA (Fig. 1). The observed changes in body weight were due largely to
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corresponding changes in fat mass (Fig. 2). This experiment is novel in its use of
calcium-depleted milk. The effects of dietary calcium are clearly seen in the comparison
of the depleted vs. replete milk diet groups and of the soy diets/ACEi/BCAA diets with
and without added calcium. When comparing the restricted diet groups it is apparent that
calcium is responsible for ~35% of milk’s effect on fat loss, the ACEi/BCAA
combination is accountable for ~54%, leaving the remaining 10% of milk’s effect
unaccounted for.
Consistent with our previous data10, 43, [Ca2+]i was decreased in all high-calcium
diet groups, indicating that the source of calcium provided in this experiment had no
effect on [Ca2+]i. [Ca2+]i is increased in response to high levels of circulating calcitriol10,
and promotes FAS expression and activity, as well as inhibiting lipolysis. This study
corresponds with previous data in that groups consuming the most dietary calcium have
the lowest [Ca2+]i42, 43, the highest levels of lipolysis10, 16, 43, and the lowest FAS
expression10, 43. Milk also produces a non-calcium related weight reduction which
appears to be due in large part to ACEi and BCAA. This effect is clearly unrelated to
calcium-signaling, as it is apparent despite low levels of [Ca2+]i.
Although about 50% of milk’s anti-obesity effect is due in part to both ACEi and
BCAA (Fig. 2), data from the present study cannot distinguish which plays a greater role.
However, we previously found that the dairy ACE inhibitor given alone was only
responsible for 10-15% of the effect of milk91, suggesting that the large effects of the
ACEi/BCAA combination in the present study are mostly attributable to the supplemental
BCAA. Data from this study indicate that neither BCAA nor ACE inhibition exerts any
effect on 11-β-HSD expression92. However, since AII has been shown to stimulate
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cortisol release36, ACE inhibition may still exert an effect on central adiposity. AII also
affects adipocytes in their differentiation69 and lipid accumulation20 phases. Although
AII has classically been considered an important regulator of blood pressure and fluid
and electrolyte balance93, 94, its link to differentiation and lipid accumulation is well
established64, 95. AII works via AT2 receptor to induce prostacyclin production by
adipocytes69. This then induces preadipocytes to differentiate. AII also stimulates
cortisol release via the AT1 receptor36, which also induces adipocyte differentiation25. In
addition, FAS gene expression is up-regulated by AII resulting in increased activity of the
FAS enzyme and lipid accumulation20. ACE inhibition, therefore, decreases the amount
of preadipocyte differentiation and fatty acid synthesis and storage.
Although the primary effect of the BCAAs would appear to be maintenance of
muscle mass, BCAA supplementation exerted a substantial effect on adiposity. Although
the mechanism of this effect is not yet clear, protein synthesis is an energetically
expensive process, requiring 2 ATPs and 2 GTPs for each peptide bond formed. It is
likely that BCAAs play a role in decreased FAS expression by using the body’s pool of
energy producing substrates rather than allowing them to enter the fatty acid synthesis
pathway. Accordingly, we propose that the effects of BCAA on adiposity may be due to
the energy demand resulting from increased protein synthesis.
The BCAA appear to have contributed to muscle maintenance during calorie
restriction. The fact that mice consuming all three of the milk-based diets gained
gastrocnemius muscle mass during calorie restriction was unexpected. However, it is
notable that the mice on all restricted diets appeared to be highly active compared to
those on the ad libitum diet. Activity was not measured, per se, but those caring for the
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animals reported a noticeable difference in the mice’s waking, sleeping, and moving
habits. It has been shown repeatedly that exercise causes temporary muscle protein
catabolism, but when adequate protein and energy are supplied, anabolism returns,
promoting muscle gain96-98. Leucine contributes significantly to muscle anabolism via
the mTOR pathway leading to protein synthesis76, 99, 100. Likewise, leucine also has a
muscle sparing effect during energy restriction21, 80, 101, 102. During weight loss studies
comparing the effects of differing amounts of dietary protein on body composition, it was
found that high protein diets promoted fat and weight loss, and attenuated lean tissue
loss21, 80.
Changes in soleus weights showed a different pattern than gastrocnemius. While
the depleted and replete milk diet groups neither lost nor gained soleus mass, the intact
milk group gained soleus mass compared to the ad libitum- fed group, and the soy groups
with added dairy components had soleus weights that fell between the ad libitum and the
restricted basal group muscle weights. The difference between the results for the
different muscles may have to do with the nature of the activity and the muscles being
exercised. Mice on restricted diets tended to bounce on their hind limbs, exercising their
gastrocnemius but not their soleus muscles. The soleus muscle made of slow-twitch
fibers, and is used primarily in posture rather than movement, therefore exerting less of a
demand on body leucine supply than its fast-twitch counterpart, gastrocnemius. Because
the soleus muscle was not being exercised, it did not experience the same gain in size as
the gastrocnemius, and may therefore be viewed as a better indicator of the BCAA’s
influence on non-exercised muscle. Alternately, the gastrocnemius muscle is glycolytic,
using large amounts of glucose during exercise, requiring the body to maintain blood
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glucose via gluconeogenesis. Usually during exercise and starvation this process is
supplied by breaking down lean tissue; however, a diet high in the BCAA, which are
used preferentially in gluconeogenesis, provides the body with alternative substrates for
maintaining glucose. Recent studies have shown that voluntary endurance exercise
concurrent with diets supplemented with amino acids favors increase in both muscle
types103. The question remains as to why the milk diet group gained soleus muscle weight
while the other diet groups either maintained or lost muscle weight, even though
consuming comparable quantities of BCAA. There may be a synergistic relationship
between the leucine in milk and the unidentified active dairy component
In conclusion, we have shown that calcium, ACEi and BCAA all contribute to the
anti-obesity effect of milk by decreasing weight and fat mass through increased lipolysis,
and increasing or maintaining muscle mass. We have also demonstrated that FAS and
11-β-HSD expression are decreased by a calcium- dependent mechanism, but also by the
ACEi/BCAA mixture and unidentified components in milk. Additional studies will be
needed to separate the effects of ACEi from BCAA, and to determine the identities of the
unknown compounds responsible for altering fat metabolism.
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